These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 5982217)

  • 1. [Basal metabolism in various liver diseases].
    Maslova KK; Iartseva AM
    Ter Arkh; 1966 Jan; 38(1):65-8. PubMed ID: 5982217
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interrelations between lipid metabolism and liver pathology].
    Serrera Contreras JL; Molina Sánchez C
    Rev Clin Esp; 1974 May; 133(4):339-52. PubMed ID: 4409893
    [No Abstract]   [Full Text] [Related]  

  • 3. Erythropoietin alterations in human liver disease.
    Mirand EA; Murphy GP
    N Y State J Med; 1971 Apr; 71(8):860-4. PubMed ID: 5279354
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of the metabolism of tryptophane in various hepato-intestinal diseases. II. Frequency of anomalies in neoplastic diseases].
    Lemonnier A; Lemonnier F; Chevrel B; Charpentier C; Caroli J
    Rev Fr Etud Clin Biol; 1967 Feb; 12(2):162-9. PubMed ID: 6058679
    [No Abstract]   [Full Text] [Related]  

  • 5. [Adrenaline-induced glycogenolysis and lipolysis in chronic liver diseases. I. Abnormalities of glycide metabolism].
    Holík K; Rysánek K; Malinovská V; Parák S
    Vnitr Lek; 1973 Sep; 19(9):852-9. PubMed ID: 4745976
    [No Abstract]   [Full Text] [Related]  

  • 6. Iron in NASH, chronic liver diseases and HCC: how much iron is too much?
    Pietrangelo A
    J Hepatol; 2009 Feb; 50(2):249-51. PubMed ID: 19070915
    [No Abstract]   [Full Text] [Related]  

  • 7. [Analysis of glycoprotein-bound sialic acid in the blood and tissues; with special reference to the fluctuations in liver diseases and liver neoplasms].
    Matsuzaki S; Itakura M; Iwamura K; Kamiguchi H
    Rinsho Byori; 1983 Mar; Suppl 54():175-81. PubMed ID: 6887573
    [No Abstract]   [Full Text] [Related]  

  • 8. [Ribonucleic acid composition of normal, hyperplastic & neoplastic rat liver].
    PILERI A; MARAINI G; CAMURATI P; GAVOSTO F
    Boll Soc Ital Biol Sper; 1959 May; 35(10):532-4. PubMed ID: 13662461
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical aspects of bile acid metabolism in liver diseases.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Jan; 7(1):7-29. PubMed ID: 6281949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of CD34-positive sinusoidal endothelial cells in patients with HBV-associated chronic liver diseases.
    Ohmori S; Shiraki K; Sugimoto K; Yamanaka Y; Yamaguchi Y; Saitou Y; Fujikawa K; Murata K; Nakano T
    Int J Mol Med; 2004 Aug; 14(2):179-84. PubMed ID: 15254762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokeratin immunohistochemistry in liver histopatology.
    Van Eyken P
    Adv Clin Path; 2000 Oct; 4(4):201-11. PubMed ID: 11436159
    [No Abstract]   [Full Text] [Related]  

  • 12. [Heterogeneous reactivity of alpha-fetoprotein from primary liver neoplasms and benign liver diseases with lectins].
    Aoyagi Y; Ichida F
    Rinsho Byori; 1983 Dec; 31(12):1286-93. PubMed ID: 6202901
    [No Abstract]   [Full Text] [Related]  

  • 13. The clinical and pathogenetic significance of estrogen receptor-beta expression in chronic liver diseases and liver carcinoma.
    Iavarone M; Lampertico P; Seletti C; Francesca Donato M; Ronchi G; del Ninno E; Colombo M
    Cancer; 2003 Aug; 98(3):529-34. PubMed ID: 12879470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and experimental studies on collagen metabolism in hepatic disorders.
    Kucharz E
    Med Interne; 1984; 22(2):129-40. PubMed ID: 6330869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Studies on catecholamine metabolism in liver diseases--with special reference to hepatic encephalopathy].
    Miura T
    Igaku Kenkyu; 1983 Dec; 53(6):327-40. PubMed ID: 6679164
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatic and blood lead levels in patients with chronic liver disease.
    Castilla L; Castro M; Grilo A; Guerrero P; Lopez-Artiguez M; Soria ML; Martinez-Parra D
    Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):243-9. PubMed ID: 7743306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug disposition in liver disease.
    Fruncillo RJ
    Am Fam Physician; 1982 Dec; 26(6):167-9. PubMed ID: 7148640
    [No Abstract]   [Full Text] [Related]  

  • 18. Androgen receptor in human liver: characterization and quantitation in normal and diseased liver.
    Eagon PK; Elm MS; Stafford EA; Porter LE
    Hepatology; 1994 Jan; 19(1):92-100. PubMed ID: 8276373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies on the urinary catecholamines in the patients with various diseases].
    Nakano Y; Sugano Y; Ezaki T; Shinbo S; Tanaka S; Nagayama Y
    Naika Hokan; 1965 Aug; 12(8):427-34. PubMed ID: 5890581
    [No Abstract]   [Full Text] [Related]  

  • 20. Proteomics in the study of liver pathology.
    Parent R; Beretta L
    J Hepatol; 2005 Jul; 43(1):177-83. PubMed ID: 15894398
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.